4//SEC Filing
CORNERSTONE THERAPEUTICS INC 4
Accession 0001209191-14-006769
CIK 0001145404operating
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 11:11 AM ET
Size
8.5 KB
Accession
0001209191-14-006769
Insider Transaction Report
Form 4
Shawver Laura
Director
Transactions
- Disposition to Issuer
Option to Purchase Common Stock (Right to Buy)
2014-02-03$4.08/sh−20,000$81,600→ 0 totalExercise: $5.42Exp: 2022-06-06→ Common Stock (20,000 underlying) - Disposition to Issuer
Option to Purchase Common Stock (Right to Buy)
2014-02-03$1.16/sh−15,000$17,400→ 0 totalExercise: $8.34Exp: 2023-05-22→ Common Stock (15,000 underlying)
Footnotes (2)
- [F1]Pursuant to the Agreement and Plan of Merger (the "Agreement") by and among Chiesi Farmaceutici S.p.A., Chiesi U.S. Corporation, and Cornerstone Therapeutics Inc., dated as of September 15, 2013, on the effective date of the merger contemplated by the Agreement (the "Merger"), this option, which was fully vested, was cancelled in exchange for a cash payment equal to the product of (i) the excess of $9.50 over the exercise price per share of the option and (ii) the total number of shares underlying the option.
- [F2]This option, which provided for vesting in equal monthly increments over a one-year period, was cancelled in the Merger in exchange for a cash payment equal to the product of (i) the excess of $9.50 over the exercise price per share of the option and (ii) the total number of shares underlying the option.
Documents
Issuer
CORNERSTONE THERAPEUTICS INC
CIK 0001145404
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001145404
Filing Metadata
- Form type
- 4
- Filed
- Feb 3, 7:00 PM ET
- Accepted
- Feb 4, 11:11 AM ET
- Size
- 8.5 KB